论文部分内容阅读
目的:分析对比磺脲类药物或胰岛素与二甲双胍联合治疗Ⅱ型糖尿病的临床疗效。方法:将90例Ⅱ型糖尿病平均分为实验组与对照组。实验组应用胰岛素+二甲双胍治疗,对照组应用格列美脲+二甲双胍治疗。结果:实验组FPG及2h FPG水平显著低于治疗前,且低于对照组(P<0.05)。实验组并发症发生率为6.67%,显著低于对照组的28.89%(P<0.05)。结论:胰岛素与二甲双胍联合治疗初发Ⅱ型糖尿病疗效确切,值得临床推广。
OBJECTIVE: To analyze the clinical efficacy of sulfonylureas or insulin in combination with metformin in the treatment of type 2 diabetes mellitus. Methods: Ninety patients with type 2 diabetes were equally divided into experimental group and control group. The experimental group was treated with insulin + metformin, while the control group was treated with glimepiride + metformin. Results: The levels of FPG and 2h FPG in experimental group were significantly lower than those before treatment and lower than those in control group (P <0.05). The incidence of complications in the experimental group was 6.67%, which was significantly lower than that in the control group (28.89%, P <0.05). Conclusion: The combination of insulin and metformin is effective in treating type Ⅱ diabetes mellitus, which is worthy of clinical promotion.